Articles from Dermatology News (May 1, 2020)

Title	Author	Type	Words
Almost half of practices furloughing staff, one-fifth have layoffs.	Terry, Ken		549
Calcipotriol helped with itch, wound healing in phase 2 EB study.	Freeman, Sara	Clinical report	725
CMS loosens telehealth, clinician scope-of-practice rules.	Terry, Ken		579
Continuous long-term dupilumab is best strategy.	Jancin, Bruce		1166
Coping with COVID-19: Things may never be the same.	Coldiron, Brett M.		1040
COVID-19: Dermatology a natural for the pivot to telemedicine.	Salamon, Maureen		1467
COVID-19: What now?	Eastern, Joseph S.		824
D.C.-area black population faces increased mortality risk.	Brunk, Doug		641
Dermatologists describe COVID-19 skin manifestations.	Otto, M. Alexander		631
Focus on factors that can be controlled during surgery for a good cosmetic result.	Craven, Jeff		1197
iPLEDGE allows at-home pregnancy tests during pandemic.	Haelle, Tara		713
Mother of pearl: The power of pearl powder.	Baumann, Leslie S.		1564
NCCN panel: Defer nonurgent skin cancer care.	Otto, M. Alexander		613
New melanoma treatments linked to mortality decline.	Franki, Richard		483
Oral propranolol shown to be safe in PHACE.	Jancin, Bruce		696
Overcoming COVID-related stress.	Benabio, Jeffrey		767
Pemphigoid gestationis.	Hanson, Holly		400
Private equity: Salvation or death sentence?	Ault, Alicia		3512
Stage I mycosis fungoides is the general dermatologist's bailiwick.	Jancin, Bruce		736
Study describes PPE-related skin effects in Chinese doctors, nurses.	Otto, M. Alexander		504
Study examines heritability of psoriatic disease subtypes.	Nogrady, Bianca		435
Study finds spironolactone doesn't boost breast cancer recurrence.	Jancin, Bruce		477
Teledermoscopy using smartphones fails to boost skin cancer detection.	London, Susan		436
The resurgence of hydroxychloroquine.	Talakoub, Lily; Wesley, Naissan O.	Drug overview	903
What is known as perioral dermatitis often not just around the mouth.	Jancin, Bruce		394